Skip to main content
Erschienen in: Annals of Surgical Oncology 2/2018

20.11.2017 | Gynecologic Oncology

Prospective Assessment of First-Year Quality of Life After Pelvic Exenteration for Gynecologic Malignancy: A French Multicentric Study

verfasst von: A. Martinez, PhD, MD, T. Filleron, PhD, MD, P. Rouanet, PhD, MD, P. Méeus, PhD, MD, E. Lambaudie, PhD, MD, J. M. Classe, PhD, MD, F. Foucher, MD, F. Narducci, MD, S. Gouy, PhD, MD, F. Guyon, PhD, MD, F. Marchal, PhD, MD, E. Jouve, MD, P. E. Colombo, PhD, MD, A. Mourregot, MD, M. Rivoire, PhD, MD, N. Chopin, MD, G. Houvenaeghel, PhD, MD, I. Jaffre, MD, J. Leveque, PhD, MD, V. Lavoue, PhD, MD, E. Leblanc, PhD, MD, P. Morice, PhD, MD, E. Stoeckle, PhD, MD, J. L. Verheaghe, MD, D. Querleu, PhD, MD, G. Ferron, PhD, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Pelvic exenteration remains one of the most mutilating procedures, with important postoperative morbidity, an altered body image, and long-term physical and psychosocial concerns. This study aimed to assess quality of life (QOL) during the first year after pelvic exenteration for gynecologic malignancy performed with curative intent.

Methods

A French multicentric prospective study was performed by including patients who underwent pelvic exenteration. Quality of life by measurement of functional and symptom scales was assessed using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 (version 3.0) and the EORTC QLQ-OV28 questionnaires before surgery, at baseline, and 1, 3, 6, and 12 months after the procedure.

Results

The study enrolled 97 patients. Quality of life including physical, personal, fatigue, and anorexia reported in the QLQ-C30 was significantly reduced 1 month postoperatively and improved at least to baseline level 1 year after the procedure. Body image also was significantly reduced 1 month postoperatively. Global health, emotional, dyspnea, and anorexia items were significantly improved 1 year after surgery compared with baseline values. Unlike younger patients, elderly patients did not regain physical and social activities after pelvic exenteration.

Conclusions

Therapeutic decision on performing a pelvic exenteration can have a severe and permanent impact on all aspects of patients’ QOL. Deterioration of QOL was most significant during the first 3 months after surgery. Elderly patients were the only group of patients with permanent decreased physical and social function. Preoperative evaluation and postoperative follow-up evaluation should include health-related QOL instruments, counseling by a multidisciplinary team to cover all aspects concerning stoma care, sexual function, and long-term concerns after surgery.
Literatur
1.
Zurück zum Zitat Marnitz S, Köhler C, Müller M, Behrens K, Hasenbein K, Schneider A. Indications for primary and secondary exenterations in patients with cervical cancer. Gynecol Oncol. 2006;103:1023–30.CrossRefPubMed Marnitz S, Köhler C, Müller M, Behrens K, Hasenbein K, Schneider A. Indications for primary and secondary exenterations in patients with cervical cancer. Gynecol Oncol. 2006;103:1023–30.CrossRefPubMed
2.
Zurück zum Zitat Maggioni A, Roviglione G, Landoni F, et al. Pelvic exenteration: ten-year experience at the European Institute of Oncology in Milan. Gynecol Oncol. 2009;114:64–6.CrossRefPubMed Maggioni A, Roviglione G, Landoni F, et al. Pelvic exenteration: ten-year experience at the European Institute of Oncology in Milan. Gynecol Oncol. 2009;114:64–6.CrossRefPubMed
3.
Zurück zum Zitat Ungar L, Palafavi L, Novak Z. Primary pelvic exenteration in cervical cancer patients. Gynecol Oncol. 2008;111:S9–12.CrossRefPubMed Ungar L, Palafavi L, Novak Z. Primary pelvic exenteration in cervical cancer patients. Gynecol Oncol. 2008;111:S9–12.CrossRefPubMed
4.
Zurück zum Zitat Westin SN, Rallapalli V, Fellman B, Urbauer DL, Pal N, Frumovitz MM, et al. Overall survival after pelvic exenteration for gynecologic malignancy. Gynecol Oncol. 2014;134:546–51.CrossRefPubMedPubMedCentral Westin SN, Rallapalli V, Fellman B, Urbauer DL, Pal N, Frumovitz MM, et al. Overall survival after pelvic exenteration for gynecologic malignancy. Gynecol Oncol. 2014;134:546–51.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Chiva LM, Lapuente F, González-Cortijo L, González-Martín A, Rojo A, García JF, Carballo N. Surgical treatment of recurrent cervical cancer: state of the art and new achievements. Gynecol Oncol. 2008;110(3 Suppl 2):S60–6.CrossRefPubMed Chiva LM, Lapuente F, González-Cortijo L, González-Martín A, Rojo A, García JF, Carballo N. Surgical treatment of recurrent cervical cancer: state of the art and new achievements. Gynecol Oncol. 2008;110(3 Suppl 2):S60–6.CrossRefPubMed
6.
Zurück zum Zitat Ferron G, Gangloff D, Querleu D, Frigenza M, Torrent JJ, Picaud L, et al. Vaginal reconstruction with pedicled vertical deep inferior epigastric perforator flap (DIEP) after pelvic exenteration: a consecutive case series. Gynecol Oncol. 2015;138:603–8.CrossRefPubMed Ferron G, Gangloff D, Querleu D, Frigenza M, Torrent JJ, Picaud L, et al. Vaginal reconstruction with pedicled vertical deep inferior epigastric perforator flap (DIEP) after pelvic exenteration: a consecutive case series. Gynecol Oncol. 2015;138:603–8.CrossRefPubMed
7.
Zurück zum Zitat Jurado M, Bazán A, Alcázar JL, Garcia-Tutor E. Primary vaginal reconstruction at the time of pelvic exenteration for gynecologic cancer: morbidity revisited. Ann Surg Oncol. 2009;16:121–7.CrossRefPubMed Jurado M, Bazán A, Alcázar JL, Garcia-Tutor E. Primary vaginal reconstruction at the time of pelvic exenteration for gynecologic cancer: morbidity revisited. Ann Surg Oncol. 2009;16:121–7.CrossRefPubMed
8.
Zurück zum Zitat Harji DP, Griffiths B, Velikova G, Sagar PM, Brown J. Systematic review of health-related quality of life in patients undergoing pelvic exenteration. Eur J Surg Oncol. 2016;42:1132–45.CrossRefPubMed Harji DP, Griffiths B, Velikova G, Sagar PM, Brown J. Systematic review of health-related quality of life in patients undergoing pelvic exenteration. Eur J Surg Oncol. 2016;42:1132–45.CrossRefPubMed
9.
Zurück zum Zitat Rezk YA, Hurley KE, Carter J, Dao F, Bochner BH, Aubey JJ, et al. A prospective study of quality of life in patients undergoing pelvic exenteration: interim results. Gynecol Oncol. 2013;128:191–7.CrossRefPubMed Rezk YA, Hurley KE, Carter J, Dao F, Bochner BH, Aubey JJ, et al. A prospective study of quality of life in patients undergoing pelvic exenteration: interim results. Gynecol Oncol. 2013;128:191–7.CrossRefPubMed
10.
Zurück zum Zitat Martinez A, Filleron T, Vitse L, et al. Laparoscopic pelvic exenteration for gynaecological malignancy: is there any advantage? Gynecol Oncol. 2011;120:374–9.CrossRefPubMed Martinez A, Filleron T, Vitse L, et al. Laparoscopic pelvic exenteration for gynaecological malignancy: is there any advantage? Gynecol Oncol. 2011;120:374–9.CrossRefPubMed
11.
Zurück zum Zitat Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76.CrossRefPubMed Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76.CrossRefPubMed
12.
Zurück zum Zitat Cull A, Howat S, Greimel E, et al. Development of a European Organization for Research and Treatment of Cancer questionnaire module to assess the quality of life of ovarian cancer patients in clinical trials: a progress report. Eur J Cancer. 2001;37:47–53.CrossRefPubMed Cull A, Howat S, Greimel E, et al. Development of a European Organization for Research and Treatment of Cancer questionnaire module to assess the quality of life of ovarian cancer patients in clinical trials: a progress report. Eur J Cancer. 2001;37:47–53.CrossRefPubMed
13.
Zurück zum Zitat Greimel E, Bottomley A, Cull A, et al. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer. Eur J Cancer. 2003;39:1402–8.CrossRefPubMed Greimel E, Bottomley A, Cull A, et al. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer. Eur J Cancer. 2003;39:1402–8.CrossRefPubMed
14.
15.
Zurück zum Zitat Höckel M. Laterally extended endopelvic resection (LEER): principles and practice. Gynecol Oncol. 2008;111:S13–7CrossRefPubMed Höckel M. Laterally extended endopelvic resection (LEER): principles and practice. Gynecol Oncol. 2008;111:S13–7CrossRefPubMed
16.
Zurück zum Zitat Hawighorst-Knapstein S, Fusshoeller C, Franz C, Trautmann K, et al. The impact of treatment for genital cancer on quality of life and body image: results of a prospective longitudinal 10-year study. Gynecol Oncol. 2004;94:398–403.CrossRefPubMed Hawighorst-Knapstein S, Fusshoeller C, Franz C, Trautmann K, et al. The impact of treatment for genital cancer on quality of life and body image: results of a prospective longitudinal 10-year study. Gynecol Oncol. 2004;94:398–403.CrossRefPubMed
17.
Zurück zum Zitat Roos EJ, de Graeff A, van Eijkeren MA, et al. Quality of life after pelvic exenteration. Gynecol Oncol. 2004;93:610–14.CrossRefPubMed Roos EJ, de Graeff A, van Eijkeren MA, et al. Quality of life after pelvic exenteration. Gynecol Oncol. 2004;93:610–14.CrossRefPubMed
18.
19.
Zurück zum Zitat Breetvelt IS, Van Dam FS. Underreporting by cancer patients: the case of response-shift. Soc Sci Med. 1991;32:981–7.CrossRefPubMed Breetvelt IS, Van Dam FS. Underreporting by cancer patients: the case of response-shift. Soc Sci Med. 1991;32:981–7.CrossRefPubMed
20.
Zurück zum Zitat Esnaola NF, Cantor SB, Johnson ML, et al. Pain and quality of life after treatment in patients with locally recurrent rectal cancer. J Clin Oncol. 2002;20:4361–7.CrossRefPubMed Esnaola NF, Cantor SB, Johnson ML, et al. Pain and quality of life after treatment in patients with locally recurrent rectal cancer. J Clin Oncol. 2002;20:4361–7.CrossRefPubMed
21.
Zurück zum Zitat Young JM, Badgery-Parker T, Masya LM, King M, Koh C, Lynch AC, et al. Quality of life and other patient-reported outcomes following exenteration for pelvic malignancy. Br J Surg. 2014;101:277–87.CrossRefPubMed Young JM, Badgery-Parker T, Masya LM, King M, Koh C, Lynch AC, et al. Quality of life and other patient-reported outcomes following exenteration for pelvic malignancy. Br J Surg. 2014;101:277–87.CrossRefPubMed
22.
Zurück zum Zitat Austin KK, Young JM, Solomon MJ. Quality of life of survivors after pelvic exenteration for rectal cancer. Dis Colon Rectum. 2010;53:1121–6.CrossRefPubMed Austin KK, Young JM, Solomon MJ. Quality of life of survivors after pelvic exenteration for rectal cancer. Dis Colon Rectum. 2010;53:1121–6.CrossRefPubMed
23.
Zurück zum Zitat Dale W, Hemmerich J, Kamm A, Posner MC, Matthews JB, Rothman R, et al. Geriatric assessment improves prediction of surgical outcomes in older adults undergoing pancreaticoduodenectomy: a prospective cohort study. Ann Surg. 2014;259:960–5.CrossRefPubMed Dale W, Hemmerich J, Kamm A, Posner MC, Matthews JB, Rothman R, et al. Geriatric assessment improves prediction of surgical outcomes in older adults undergoing pancreaticoduodenectomy: a prospective cohort study. Ann Surg. 2014;259:960–5.CrossRefPubMed
25.
Zurück zum Zitat Dutta SC, Chang SC, Coffey CS, et al. Health-related quality of life assessment after radical cystectomy: comparison of ileal conduit with continent orthotopic neobladder. J Urol. 2002;168:164–7.CrossRefPubMed Dutta SC, Chang SC, Coffey CS, et al. Health-related quality of life assessment after radical cystectomy: comparison of ileal conduit with continent orthotopic neobladder. J Urol. 2002;168:164–7.CrossRefPubMed
26.
Zurück zum Zitat Hart S, Skinner EC, Meyerowitz BE, et al. Quality of life after radical cystectomy for bladder cancer in patients with an ileal conduit, cutaneous or urethral kock pouch. J Urol. 1999;162:77–81.CrossRefPubMed Hart S, Skinner EC, Meyerowitz BE, et al. Quality of life after radical cystectomy for bladder cancer in patients with an ileal conduit, cutaneous or urethral kock pouch. J Urol. 1999;162:77–81.CrossRefPubMed
27.
Zurück zum Zitat Forner DM, Lampe B. Ileal conduit and continent ileocecal pouch for patients undergoing pelvic exenteration: comparison of complications and quality of life. Int J Gynecol Cancer. 2011;21:403–8. Forner DM, Lampe B. Ileal conduit and continent ileocecal pouch for patients undergoing pelvic exenteration: comparison of complications and quality of life. Int J Gynecol Cancer. 2011;21:403–8.
28.
Zurück zum Zitat Gerharz EW, Mansson A, Hunt S, et al. Quality of life after cystectomy and urinary diversion: an evidence-based analysis. J Urol. 2005;174:1729–36.CrossRefPubMed Gerharz EW, Mansson A, Hunt S, et al. Quality of life after cystectomy and urinary diversion: an evidence-based analysis. J Urol. 2005;174:1729–36.CrossRefPubMed
29.
Zurück zum Zitat Chiva LM, Lapuente F, Nunez C, Ramirez PT. Ileal orthotopic neobladder after pelvic exenteration for cervical cancer. Gynecol Oncol. 2009;113:47–51.CrossRefPubMed Chiva LM, Lapuente F, Nunez C, Ramirez PT. Ileal orthotopic neobladder after pelvic exenteration for cervical cancer. Gynecol Oncol. 2009;113:47–51.CrossRefPubMed
30.
Zurück zum Zitat Goldberg GL, Sukumvanich P, Einstein MH, et al. Total pelvic exenteration: the Albert Einstein College of Medicine/Montefiore Medical Center Experience (1987–2003). Gynecol Oncol. 2006;101:261–8.CrossRefPubMed Goldberg GL, Sukumvanich P, Einstein MH, et al. Total pelvic exenteration: the Albert Einstein College of Medicine/Montefiore Medical Center Experience (1987–2003). Gynecol Oncol. 2006;101:261–8.CrossRefPubMed
31.
Zurück zum Zitat Smith HO, Genesen MC, Runowicz CD, et al. The rectus abdominis myocutaneous flap: modifications, complications, and sexual function. Cancer. 1998;83:510–20.CrossRefPubMed Smith HO, Genesen MC, Runowicz CD, et al. The rectus abdominis myocutaneous flap: modifications, complications, and sexual function. Cancer. 1998;83:510–20.CrossRefPubMed
32.
Zurück zum Zitat Ratliff CR, Gershenson DM, Morris M, et al. Sexual adjustment of patients undergoing gracilis myocutaneous flap vaginal reconstruction in conjunction with pelvic exenteration. Cancer. 1996;78:2229–35.CrossRefPubMed Ratliff CR, Gershenson DM, Morris M, et al. Sexual adjustment of patients undergoing gracilis myocutaneous flap vaginal reconstruction in conjunction with pelvic exenteration. Cancer. 1996;78:2229–35.CrossRefPubMed
33.
Zurück zum Zitat Corney RH, Crowther ME, Everett H, Howells A, Shepherd JH. Psychosexual dysfunction in women with gynaecological cancer following radical pelvic surgery. Br J Obstet Gynaecol. 1993;100:73–8.CrossRefPubMed Corney RH, Crowther ME, Everett H, Howells A, Shepherd JH. Psychosexual dysfunction in women with gynaecological cancer following radical pelvic surgery. Br J Obstet Gynaecol. 1993;100:73–8.CrossRefPubMed
34.
35.
Zurück zum Zitat Krouse R, Grant M, Ferrell B, et al. Quality of life outcomes in 599 cancer and non-cancer patients with colostomies. J Surg Res. 2007:138:79–87.CrossRefPubMed Krouse R, Grant M, Ferrell B, et al. Quality of life outcomes in 599 cancer and non-cancer patients with colostomies. J Surg Res. 2007:138:79–87.CrossRefPubMed
36.
Zurück zum Zitat Watson PG. The effects of short-term postoperative counseling on cancer/ostomy patients. Cancer Nurs. 1983;6:21–9.CrossRefPubMed Watson PG. The effects of short-term postoperative counseling on cancer/ostomy patients. Cancer Nurs. 1983;6:21–9.CrossRefPubMed
37.
Zurück zum Zitat Pomel C, Rouzier R, Pocard M, et al. Laparoscopic total pelvic exenteration for cervical cancer relapse. Gynecol Oncol. 2003;91:616–8.CrossRefPubMed Pomel C, Rouzier R, Pocard M, et al. Laparoscopic total pelvic exenteration for cervical cancer relapse. Gynecol Oncol. 2003;91:616–8.CrossRefPubMed
38.
Zurück zum Zitat Puntambekar S, Sharma V, Jamkar AV, Gadkari Y, Joshi G, Puntambekar S, et al. Our experience of laparoscopic anterior exenteration in locally advanced cervical carcinoma. J Minim Invasive Gynecol. 2016;23:396–403.CrossRefPubMed Puntambekar S, Sharma V, Jamkar AV, Gadkari Y, Joshi G, Puntambekar S, et al. Our experience of laparoscopic anterior exenteration in locally advanced cervical carcinoma. J Minim Invasive Gynecol. 2016;23:396–403.CrossRefPubMed
39.
Zurück zum Zitat de la GJ, Wilson SS, Behbakht K. Total pelvic exenteration with a split-thickness skin graft neovagina, continent orthotopic neobladder, and rectal reanastomosis, resulting in no external ostomies and adequate sexual function. Gynecol Oncol. 2009;115:312–3.CrossRefPubMed de la GJ, Wilson SS, Behbakht K. Total pelvic exenteration with a split-thickness skin graft neovagina, continent orthotopic neobladder, and rectal reanastomosis, resulting in no external ostomies and adequate sexual function. Gynecol Oncol. 2009;115:312–3.CrossRefPubMed
Metadaten
Titel
Prospective Assessment of First-Year Quality of Life After Pelvic Exenteration for Gynecologic Malignancy: A French Multicentric Study
verfasst von
A. Martinez, PhD, MD
T. Filleron, PhD, MD
P. Rouanet, PhD, MD
P. Méeus, PhD, MD
E. Lambaudie, PhD, MD
J. M. Classe, PhD, MD
F. Foucher, MD
F. Narducci, MD
S. Gouy, PhD, MD
F. Guyon, PhD, MD
F. Marchal, PhD, MD
E. Jouve, MD
P. E. Colombo, PhD, MD
A. Mourregot, MD
M. Rivoire, PhD, MD
N. Chopin, MD
G. Houvenaeghel, PhD, MD
I. Jaffre, MD
J. Leveque, PhD, MD
V. Lavoue, PhD, MD
E. Leblanc, PhD, MD
P. Morice, PhD, MD
E. Stoeckle, PhD, MD
J. L. Verheaghe, MD
D. Querleu, PhD, MD
G. Ferron, PhD, MD
Publikationsdatum
20.11.2017
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 2/2018
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-017-6120-z

Weitere Artikel der Ausgabe 2/2018

Annals of Surgical Oncology 2/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.